Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Repeated Pulmonary Metastasectomy in Patients with Osteosarcoma

골육종 환자의 반복적 폐전이 절제술

  • Lee, Jin-Gu (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Shin, Kyoo-Ho (Department of Orthopaedic Surgery, Yonsei University College of Medicine) ;
  • Park, In-Kyu (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Chung, Kyung-Young (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Song, Seung-Jun (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Kim, Dae-Joon (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine)
  • 이진구 (연세대학교 의과대학 흉부외과학교실) ;
  • 신규호 (연세대학교 의과대학 정형외과학교실) ;
  • 박인규 (연세대학교 의과대학 흉부외과학교실) ;
  • 정경영 (연세대학교 의과대학 흉부외과학교실) ;
  • 송승준 (연세대학교 의과대학 흉부외과학교실) ;
  • 김대준 (연세대학교 의과대학 흉부외과학교실)
  • Published : 2007.09.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Surgical resection is a standard treatment for pulmonary metastases in patients with osteosarcoma, but the role of performing repeated resections is not clear. This study was designed to clarify the feasibility of performing a repeated pulmonary metastasectomy and the prognostic factors for pulmonary metastases in patients with osteosarcoma. Material and Method: Between January 1990 and July 2005, 62 patients with osteosarcoma were diagnosed with pulmonary metastases and 36 patients underwent pulmonary resection. We reviewed the patients retrospectively. Result: The total number of pulmonary metastasectomies was 62 in 30 patients. Among 36 patients, 18 had a second metastasectomy, 7 had a third metastasectomy, and one patient had a fourth metastasectomy. There was no distinctive difference between the first and second metastatectomy in terms of median survival time, and the 3-year and 5-year survival rate (first resection: 20.5 months, 32.0% and 29,4%; second resection: 11.3 months, 34.9% and 34.%). However, the median survival time (7.1 months) was shorter in patients with a third metastatectomy than in patients with one metastatectomy (p=0.01). In long-term survivors, the number of female patients, patients with a disease free time longer than 12 months, patients with a single metastasis and patients with anatomic resection was larger when compared to non-long term survivors, but showed no statistical significance. Conclusion: Repeated pulmonary metastasectomy is expected to prolong survival time in patients with osteosarcoma, and is expected to increase long-term survival in selected cases. Further studies with a large number of patients are necessary.

배경: 골육종 환자의 폐전이는 외과적 절제술이 표준치료로 인정되고 있으나 반복적인 폐전이에 대한 절제술의 역할은 아직 정립되어 있지 않다. 저자들은 폐전이를 보인 골육종 환자에서 반복적인 폐전이 절제술의 생존율과 예후인자를 알아보고자 하였다. 대상 및 방법: 1990년 1월부터 2005년 7월까지 골육종 폐전이를 진단받은 62명의 환자 중 폐전이 절제술을 시행받은 36명의 환자를 대상으로 후향적 연구를 진행하였다. 결과: 36명의 환자에서 모두 62회의 폐전이 절제술을 시행했으며 18명에서 2차 폐전이 절제술을, 7명에서 3차 폐전이 절제술을, 1명에서 4차 폐전이 절제술을 시행하였다. 1차 폐전이 절제술 후 중앙 생존기간은 20.5개월, 3년 및 5년 생존율은 32.6% 및 29.4%로, 2차 폐전이절제술 후의 중앙생존기간 11.3개월, 3년 및 5년 생존율 34.9% 및 34.9%와 차이를 보이지 않았으나, 3차 폐전이 절제술 후 중앙 생존기간은 7.1개월로 유의하게 짧았다(p=0.01). 장기 생존한 군에서 비-장기 생존자에 비해 여성, 무병생존기간이 12개월 이상, 단일 전이 병소, 구역절제술 이상의 수술이 많았으나 통계학적 차이는 없었다. 결론: 골육종 환자에서 반복적인 폐전이 절제술은 유용한 치료방법이라 생각되며, 일부 환자에서는 장기 생존을 기대할 수 있었다. 예후인자에 대하여는 향후 더 많은 수의 환자를 대상으로 하는 추가적인 연구가 필요하리라 생각한다.

Keywords

References

  1. Meyers PA, Heller G, Healey JH, et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 1993;11:449-53 https://doi.org/10.1200/JCO.1993.11.3.449
  2. Bentzen SM. Prognostic factor studies in oncology: osteosarcoma as a clinical example. Int J Radiat Oncol Biol Phys 2001;49:513-8 https://doi.org/10.1016/S0360-3016(00)01507-8
  3. Huth JF, Eilber FR. Patterns of recurrence after resection of osteosarcoma of the extremity: strategies for treatment of metastases. Arch Surg 1989;124:122-6 https://doi.org/10.1001/archsurg.1989.01410010132026
  4. Ward WG, Mikaelian K, Dorey F, et al. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol 1994;12:1849-58 https://doi.org/10.1200/JCO.1994.12.9.1849
  5. Link MP, Gebhardt MC, Meyers PA. Osteosarcoma. In: Pizzo PA, Poplack DG. Principles and practice of pediatric oncology (chap.35). Baltimore, MD: Lippincott Williams and Wilkins. 2002;1051-89
  6. Han MT, Telander RL, Pairolero PC, et al. Aggressive thoracotomy for pulmonary metastatic osteogenic sarcoma in children and young adolescents. J Pediatr Surg 1981;16:928-33 https://doi.org/10.1016/S0022-3468(81)80848-2
  7. Goorin AM, Delorey MJ, Lack EE, et al. Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients. J Clin Oncol 1984;2:425-31 https://doi.org/10.1200/JCO.1984.2.5.425
  8. Pastorino U, Valente M, Gasparim M, et al. Median sternotomy and multiple lung resections for metastatic sarcomas. Eur J Cardiothorac Surg 1990;4:477-81 https://doi.org/10.1016/1010-7940(90)90169-Z
  9. Briccoli A, Rocca M, Salone M, et al. Resection of recurrent pulmonary metastases in patients with osteosarcoma. Cancer 2005;104:1721-5 https://doi.org/10.1002/cncr.21369
  10. Cotterill SJ, Wright CM, Pearce MS, et al. Stature of young people with malignant bone tumors. Pediatr Blood Cancer 2004;42:59-63 https://doi.org/10.1002/pbc.10437
  11. Glasser DB, Lane JM, Huvos AG, et al. Survival, prognosis, and therapeutic response in osteogenic sarcoma: The Memorial Hospital experience. Cancer 1992;69:698-708 https://doi.org/10.1002/1097-0142(19920401)69:7+<1992::AID-CNCR2820691721>3.0.CO;2-H
  12. Tsuchiya H, Tomita K, Mori Y, et al. Marginal excision for osteosarcoma with caffeine assisted chemotherapy. Clin Orthop 1999;358:27-35
  13. Rosen G, Huvos AG, Mosende C, et al. Chemotherapy and thoracotomy for metastatic osteogenic sarcoma: a model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery. Cancer 1978;41:841-9 https://doi.org/10.1002/1097-0142(197803)41:3<841::AID-CNCR2820410310>3.0.CO;2-Z
  14. Sohn JH, Rha SY, Jeung HC, et al. Efficacy of pre- and postoperative chemotherapy in patients with osteosarcoma of the extremities. Cancer Res Treatment 2001;33:520-526 https://doi.org/10.4143/crt.2001.33.6.520
  15. Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5,206 cases. J Thorac Cardiovasc Surg 1997;113:37-49 https://doi.org/10.1016/S0022-5223(97)70397-0
  16. Headrick JR, Miller DL, Nagomey DM, et al. Surgical treatment of hepatic and pulmonary metastases form colon cancer. Ann Thorac Surg 2001;71:975-80 https://doi.org/10.1016/S0003-4975(00)02522-4
  17. Bruland OS, Pihl A. On the current management of osteosarcoma: a critical evaluation and a proposal for a modified treatment strategy. Eur J Cancer 1997;33:1725-31 https://doi.org/10.1016/S0959-8049(97)00252-9
  18. Hong KP, Chung KY, Kin KD, Park IK. Prognostic factors affecting long term survival after operation in metastatic lung cancer. Korean J Thorac Cardiovasc Surg 1999;32:916-23